Acta Scientific Pharmacology

Research Article Volume 2 Issue 2

Development, Characterization and Transdermal Delivery of Meloxicam Entrapped in Proniosomal Gel for the Treatment of Osteoarthritis

Priyanka Maurya*, Ashutosh Kushwaha and Jai Narayan Mishra

Kailash Institute of Pharmacy and Management Gida, Gorakhpur, India

*Corresponding Author: Priyanka Maurya, Kailash Institute of Pharmacy and Management Gida, Gorakhpur, India.

Received: June 20, 2020; Published: January 30, 2021



Objective: Applying Proniosomal Gels(PGs) in transdermal drug delivery system has evoked impressive intrigue in light of their great water-solvency and biocompatibility. The point of present investigation was to get ready and describe proniosomes of Meloxicam(MLX) for osteoarthritis. which may convey these medications to focused site more effectively than and furthermore beat the issues related with oral organization of MLX.

Methodology: Proniosomes were set up by coacervation phase separation technique at that point described for molecule size, capture effectiveness (EE), zeta potential and saturation examines. Vesicular size was controlled by optical microscopy and saw as changed from 05.61 ± 0.04 to 10.30 ± 0.05 µm relying upon the convergences of range.

Results: The normal percent of drug entrapment was in range 67.2 ± 1.44 % to 76.8 ± 0.60 %. It was seen that F3 detailing was having zeta capability of MLX was - 54.6 mV so don't aggregate quickly. The drug release of MLX was 84.21% run from 84.68%. Proniosomal gel was readied read for its discharge and physicochemical qualities.

Conclusion: At last, F3 exhibited better osteoarthritis impact to improve adequacy, steadiness and to lessen symptoms and poisonousness related with the picked drugs so as to treat Osteoarthritis.

Keywords: Meloxicam; Proniosomes; Topical Delivery; Proniosomal Gel; Irritation Studies



  1. NB Mahale., et al. “Ethosomal drug delivery system : a review”. Indo American Journal of Pharmaceutical Research 5 (2011): 469-475.
  2. Paolino D., et al. “Proniosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers”. Journal of Controlled Release (2005): 106.
  3. Cal K. “Skin disposition of menthol after its application in the presence of drug substances”. Biopharmaceutics and Drug Disposition 8 (2008): 449-454.
  4. Mahrous Gamal M. “Proniosomes as a drug carrier for transdermal drug delivery of MLX, Bull pharma science”. Assiut university 33 (2010): 131-140.
  5. Mishra Ashtha., et al. “Proniosomal gel as a carrier for improved transdermal drug delivery”. Asian Journal of Pharmacy and Life sciences 1
  6. Shukla Narayan Dutt and Tiwari Manika. “Proniosomal drug delivery system: Clinical Application”. International Journal of Research in Pharmaceutical and Biomedical Science 2 (2011): 880-887.
  7. Patel N Nirav., et al. “Proniosomes for improved transdermal drug delivery: A Review, The pharma research”. A Journal of Pharmacy Research2 (2013): 62-82.
  8. Rita B and Lakshmi PK. “Preparation and evaluation of modified of proniosomal gel of localized urticaria and optimisation by statistical method”. Journal of Applied Pharmaceuticals Science (2012): 85-91.
  9. Radha GV., et al. “A Review on proniosomal drug delivery system for targeted drug action”. Journal of Basic and Clinical Pharmacy 2 (2013): 42-48.
  10. Prasanthi D., et al. “Vesicles: Mechanism of transdermal permeation: An review”. Asian Journal of Pharmaceuticals and Clinical Research 5 (2011): 18-25.
  11. Shahiwala A and Mishra A. “Studies in topical application of niosomally entrapped nimuslide”. (2002): 220-225.
  12. Malarkodi S., et al. “Proniosomal gel: An effective novel therapeutic topical delivery system”. International Journal of Pharma Tech Research4 (2013): 1754-1764.
  13. Ram Alpana., et al. “Proniosomal provesicular system for transdermal delivery of hydralazine for hypertension”. Asian Journal of Pharmaceutical and Clinical Research3 (2012): 219-225.
  14. Jain NK and vora B. “Proniosomes based transdermal drug delivery of levonorgesterol for effective contraception”. 54.2 (1998): 149-165.
  15. Yadav K and Yadav D. “Proniosomal gel: A provesicular approach for transdermal drug delivery”. Scholars Research Library (2010): 189-198.
  16. Gadekar Varsa., et al. “Formulation and evaluation of naproxen proniosomal gel for the treatment of inflammatory or degenerative disorders of the musculoskeletal system”. Journal of Drug Delivery and Therapeutics6 (2013): 36-41.
  17. Udasi Anil., et al. “Proniosomes: A novel approaches to vesicular drug delivery system”. International Journal of Pharmacy and Pharmaceuticals Science Research (2012).
  18. Kute Ashish., et al. “Development and characterization of perindopril erbumine loaded proniosomal gel”. Asian Journal of Pharmacy and Technology 2 (2012): 54-58.
  19. Loona Sandeep., et al. “Preparation and characterization of metformine proniosomal gel for treatment of diabetes mellitus”. International Journal of Pharmaceuticals Science and Research2 (2012): 108-114.
  20. Singala Samita., et al. “Proniosomes for effective topical delivery of clotrimazole: development, characterization, and performance evaluation”. Asian Journal of Pharmaceutical Sciences 4 (2012): 259-270.
  21. Rawat Singh Ashwani. “Proniosomal gel: A novel topical delivery system”. International Journal of Recent Advances of Pharmaceutical Research (2011): 1-10.
  22. Patil Hemant., et al. “Formulation development and evaluation of proniosomal gel of carvedilol”. International Journal of Pharmacy and Pharmaceuticals Science1 (2011): 191-197
  23. Kaur Amandeep. “Proniosomal gel of tretinoin for the treatment of acne vulgaris”. Journal of Applied Pharmaceutical Science 3 (2013): 81-86.
  24. Thomus Litha and Viswanand vidya. “Formulation and optimization of clotrimazole loaded proniosomal gel”. Scientia Pharmaceutica3 (2012): 731-748.
  25. Chandel A., et al. “Preparation and evaluation of proniosomal gel of neem seed oil”. International Journal of Pharmaceuticals Science and Nanotechnology (2012).
  26. Goyal Chetana., et al. “Preparation and evaluation of anti inflammatory activity of gugulipid loaded proniosomal gel”. Acta Poloniae Pharmaceutica1 (2011) :147-150.
  27. Heyder K Abbas., et al. “Preparation and in-vitro evaluation of mitoprolol tartrate proniosomal gel”. Kerbal Journal of Pharmaceuticals Science (2013).
  28. Jestin Chellian., et al. “Development and evaluation of tolterodine tartrate proniosomal gel for overactive bladder treatment”. Second international conference on chemical, biological, and medical science (2013).
  29. Lachman leon., et al. “The theory and practice of Industrial pharmacy”. Published by CBS publishers, Special edition (2009): 534.
  30. Tarek A Ahmed., et al. “Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation”. International Journal of Pharmaceutics 500 (2016): 245-254.


Citation: Priyanka Maurya. “Development, Characterization and Transdermal Delivery of Meloxicam Entrapped in Proniosomal Gel for the Treatment of Osteoarthritis".Acta Scientific Pharmacology 2.2 (2021):.


Acceptance rate36%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US